PubMed Health⌕ Search

PubMed · 10205734

[Stroop test and schizophrenia].

Abstract

Utilization of the Stroop test with schizophrenic subjects is reviewed from 32 studies published since 1960. This test, in which subject has to name the color of color-words which are congruent or incongruent, is much used as a selective attention test. Its specific disturbance in schizophrenics would confirm the overload of consciousness with unsignificant non filtered information, probably due to lowering of frontal functions. Stroop effect is not always raised in these patients, especially when general slowing is taken into account. Technical differences modify the test power and can explain contradictory results. The thought disorder symptom seems the most correlated with the results of the test, and particular sensitiveness of paranoïd form has been argued. Neuroleptics do not seem to act on Stroop effect. Factors explaining the great variability of patients in this test are not fully put in light. One hypothesis, already raised, is that the test is linked to a particular attentional constitutional aptitude, and whose relations with the illness are to be explained.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Grapperon, M Delage. [Stroop test and schizophrenia].. https://pubmed.ncbi.nlm.nih.gov/10205734/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗